JP2018536655A5 - - Google Patents

Download PDF

Info

Publication number
JP2018536655A5
JP2018536655A5 JP2018522788A JP2018522788A JP2018536655A5 JP 2018536655 A5 JP2018536655 A5 JP 2018536655A5 JP 2018522788 A JP2018522788 A JP 2018522788A JP 2018522788 A JP2018522788 A JP 2018522788A JP 2018536655 A5 JP2018536655 A5 JP 2018536655A5
Authority
JP
Japan
Prior art keywords
composition
peg
peptide
seq
paclitaxel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018522788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018536655A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/060276 external-priority patent/WO2017079403A2/en
Publication of JP2018536655A publication Critical patent/JP2018536655A/ja
Publication of JP2018536655A5 publication Critical patent/JP2018536655A5/ja
Withdrawn legal-status Critical Current

Links

JP2018522788A 2015-11-03 2016-11-03 ポリマーナノ粒子 Withdrawn JP2018536655A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562250137P 2015-11-03 2015-11-03
US62/250,137 2015-11-03
US201662358373P 2016-07-05 2016-07-05
US62/358,373 2016-07-05
PCT/US2016/060276 WO2017079403A2 (en) 2015-11-03 2016-11-03 Polymeric nanoparticles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021034338A Division JP2021088603A (ja) 2015-11-03 2021-03-04 ポリマーナノ粒子

Publications (2)

Publication Number Publication Date
JP2018536655A JP2018536655A (ja) 2018-12-13
JP2018536655A5 true JP2018536655A5 (OSRAM) 2019-12-05

Family

ID=58662753

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018522788A Withdrawn JP2018536655A (ja) 2015-11-03 2016-11-03 ポリマーナノ粒子
JP2021034338A Pending JP2021088603A (ja) 2015-11-03 2021-03-04 ポリマーナノ粒子
JP2022068269A Pending JP2022092069A (ja) 2015-11-03 2022-04-18 ポリマーナノ粒子

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021034338A Pending JP2021088603A (ja) 2015-11-03 2021-03-04 ポリマーナノ粒子
JP2022068269A Pending JP2022092069A (ja) 2015-11-03 2022-04-18 ポリマーナノ粒子

Country Status (5)

Country Link
US (2) US20190133963A1 (OSRAM)
EP (1) EP3548009A4 (OSRAM)
JP (3) JP2018536655A (OSRAM)
CN (2) CN114632069A (OSRAM)
WO (1) WO2017079403A2 (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021504475A (ja) * 2017-11-22 2021-02-15 ヒルストリーム・バイオファーマ・インコーポレイテッド ボルテゾミブを含むポリマーナノ粒子
CN109394731B (zh) * 2018-12-14 2023-06-02 南方医科大学 一种负载治疗肾缺血再灌注损伤药物纳米粒子的制备方法
AU2021300174A1 (en) * 2020-06-30 2023-01-19 Tharimmune, Inc. Nanoparticles and methods of manufacture thereof
CN113384534A (zh) * 2021-06-17 2021-09-14 曲阜师范大学 一种氧化石墨烯基复合纳米给药系统及其制备方法
ES3035530T3 (en) 2023-03-09 2025-09-04 Minneamrita Therapeutics Llc Drug combination for the treatment of stomach cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006232310B9 (en) * 2005-04-06 2011-07-21 Ibc Pharmaceuticals, Inc. Improved stably tethered structures of defined compositions with multiple functions or binding specificities
US20100068786A1 (en) * 2008-09-16 2010-03-18 Chmielewski Jean A Methods and compositions for reversing p-glycoprotein medicated drug resistance
JP5855568B2 (ja) * 2009-09-15 2016-02-09 セルリアン・ファーマ・インコーポレイテッド 癌の治療法
CA2849378A1 (en) * 2011-09-21 2013-03-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Nano delivery systems for sirna
US20140242180A1 (en) * 2011-10-13 2014-08-28 Case Western Reserve University Nanoparticles for controlling bleeding and drug delivery
US9511152B2 (en) * 2012-04-05 2016-12-06 The Board Of Regents Of The University Of Texas System Multicolored pH-activatable fluorescence nanoplatform
EP3778696A1 (en) * 2012-04-23 2021-02-17 NanoProteagen Ltd. Polymeric nanoparticles and a process of preparation thereof
WO2014165829A2 (en) * 2013-04-05 2014-10-09 Igdrasol Nanoparticle formulations
US9522114B1 (en) * 2014-03-27 2016-12-20 University Of South Florida Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin

Similar Documents

Publication Publication Date Title
JP2018536655A5 (OSRAM)
Yadav et al. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
JP2019537600A5 (OSRAM)
Niu et al. Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells
JP2013503174A5 (OSRAM)
JP2012522055A5 (OSRAM)
Harrisson et al. Nanoparticles with in vivo anticancer activity from polymer prodrug amphiphiles prepared by living radical polymerization
Houdaihed et al. Overcoming the road blocks: advancement of block copolymer micelles for cancer therapy in the clinic
Aguilar et al. On-demand drug release and hyperthermia therapy applications of thermoresponsive poly-(NIPAAm-co-HMAAm)/polyurethane core-shell nanofiber mat on non-vascular nitinol stents
JP2019521180A5 (OSRAM)
JP2010514787A5 (OSRAM)
JP2014531456A5 (OSRAM)
JP2013504630A5 (OSRAM)
WO2008081927A1 (ja) 抗癌剤の併用による癌治療方法
JP2013527233A5 (OSRAM)
JP2010180210A5 (OSRAM)
JP2012523435A5 (OSRAM)
WO2013044219A1 (en) Methods of treating cancers with therapeutic nanoparticles
RU2015143490A (ru) Способы лечения рака мочевого пузыря
L. Beretta et al. Engineering nanomedicines to overcome multidrug resistance in cancer therapy
Jeetah et al. Polymeric nanomicelles for sustained delivery of anti-cancer drugs
JP2011520921A5 (OSRAM)
JP2017514800A5 (OSRAM)
Cao et al. Polymer nanoparticulate drug delivery and combination cancer therapy
Bhattacharya et al. Unveiling the therapeutic potential of cabozantinib-loaded poly D, L-lactic-co-glycolic acid and polysarcosine nanoparticles in inducing apoptosis and cytotoxicity in human HepG2 hepatocellular carcinoma cell lines and in vivo anti-tumor activity in SCID female mice